Dick de Zeeuw Selected Research

endothelium-dependent hyperpolarization factor (EDHF)

2/2009	Renal endothelial function and blood flow predict the individual susceptibility to adriamycin-induced renal damage.
11/2006	Altered myogenic constriction and endothelium-derived hyperpolarizing factor-mediated relaxation in small mesenteric arteries of hypertensive subtotally nephrectomized rats.
4/2003	Coronary myogenic constriction antagonizes EDHF-mediated dilation: role of KCa channels.
3/2003	Endothelial dysfunction and infarct-size relate to impaired EDHF response in rat experimental chronic heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dick de Zeeuw Research Topics

Disease

120	Type 2 Diabetes Mellitus (MODY) 01/2022 - 04/2003
79	Albuminuria 01/2022 - 07/2002
48	Chronic Renal Insufficiency 01/2022 - 08/2003
48	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 04/2003
41	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 06/2004
37	Proteinuria 10/2021 - 02/2002
35	Heart Failure 01/2022 - 03/2003
26	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2004
22	Renal Insufficiency (Renal Failure) 01/2022 - 04/2003
21	Kidney Diseases (Kidney Disease) 01/2022 - 04/2003
21	Hypertension (High Blood Pressure) 01/2021 - 04/2003
18	Myocardial Infarction 01/2022 - 01/2004
18	Body Weight (Weight, Body) 01/2022 - 03/2004
14	Stroke (Strokes) 07/2021 - 04/2007
7	Diabetes Mellitus 01/2019 - 10/2005
7	Anemia 10/2017 - 03/2005
6	Disease Progression 10/2021 - 06/2007
5	Infections 12/2021 - 08/2013
5	Hyperkalemia 05/2021 - 03/2005
5	Weight Gain 01/2018 - 06/2007
4	Inflammation (Inflammations) 10/2015 - 01/2011
3	Edema (Dropsy) 12/2021 - 05/2014
3	Hypotension (Low Blood Pressure) 01/2020 - 12/2012
3	Obesity 10/2018 - 12/2002
3	Fibrosis (Cirrhosis) 10/2015 - 12/2007
3	Hypoglycemia (Reactive Hypoglycemia) 09/2015 - 03/2011
3	Drug-Related Side Effects and Adverse Reactions 01/2015 - 12/2011
3	Nephrosis 09/2005 - 06/2003
3	Infarction (Infarctions) 03/2004 - 03/2003
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 12/2018
2	Vascular Diseases (Vascular Disease) 01/2021 - 01/2004
2	Neoplasms (Cancer) 01/2020 - 02/2002
2	Ischemic Stroke 01/2019 - 06/2011

Drug/Important Bio-Agent (IBA)

72	CreatinineIBA 12/2021 - 09/2002
51	AlbuminsIBA 12/2021 - 07/2003
41	CanagliflozinIBA 01/2022 - 08/2013
30	Losartan (Cozaar)FDA LinkGeneric 10/2021 - 09/2002
23	Pharmaceutical PreparationsIBA 01/2021 - 02/2002
20	Angiotensin IIIBA 10/2017 - 06/2004
19	Angiotensin Receptor AntagonistsIBA 10/2017 - 04/2003
18	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2006
18	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2005
17	AtrasentanIBA 01/2022 - 05/2014
17	SodiumIBA 01/2022 - 04/2002
17	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2017 - 07/2003
14	Hemoglobins (Hemoglobin)IBA 01/2020 - 04/2003
13	Irbesartan FDA LinkGeneric 10/2017 - 09/2003
13	Antihypertensive Agents (Antihypertensives)IBA 11/2013 - 03/2002
12	CholesterolIBA 01/2020 - 06/2004
10	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2014
10	Sodium-Glucose Transport ProteinsIBA 01/2022 - 03/2015
9	Endothelin Receptor AntagonistsIBA 01/2022 - 01/2011
9	SymportersIBA 01/2022 - 08/2013
9	Proteins (Proteins, Gene)FDA Link 03/2015 - 02/2002
8	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 12/2009
8	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2018 - 06/2003
7	DiureticsIBA 01/2021 - 12/2002
7	aliskiren FDA Link 12/2018 - 05/2009
7	Darbepoetin alfa (Aranesp)FDA Link 10/2017 - 03/2005
7	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2009 - 02/2002
6	PotassiumIBA 10/2021 - 12/2012
6	Blood Glucose (Blood Sugar)IBA 01/2020 - 03/2007
6	Lisinopril (Prinivil)FDA LinkGeneric 01/2017 - 09/2002
6	Insulin (Novolin)FDA Link 09/2015 - 10/2005
6	LipidsIBA 03/2015 - 03/2007
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2019 - 06/2011
5	bardoxolone methylIBA 12/2014 - 01/2013
4	Endothelin A ReceptorIBA 11/2019 - 05/2014
4	LDL CholesterolIBA 08/2014 - 06/2011
4	C-Reactive ProteinIBA 10/2011 - 01/2004
4	endothelium-dependent hyperpolarization factor (EDHF)IBA 02/2009 - 03/2003
4	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 05/2008 - 05/2004
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 09/2015
3	HDL CholesterolIBA 01/2020 - 04/2007
3	Serum AlbuminIBA 01/2020 - 04/2003
3	Uric Acid (Urate)IBA 01/2020 - 07/2011
3	Rosuvastatin Calcium (Crestor)FDA Link 12/2019 - 03/2015
3	Atorvastatin (Lipitor)FDA Link 12/2019 - 03/2015
3	dapagliflozinIBA 01/2019 - 10/2017
3	pro-brain natriuretic peptide (1-76)IBA 12/2018 - 01/2010
3	glucuronyl glucosamine glycan sulfate (sulodexide)IBA 11/2016 - 11/2011
3	Vitamin D FDA LinkGeneric 12/2015 - 02/2007
3	Hypoglycemic Agents (Hypoglycemics)IBA 09/2015 - 10/2005
3	Calcitriol Receptors (Calcitriol Receptor)IBA 03/2015 - 11/2010
3	Renin InhibitorsIBA 12/2012 - 05/2009
3	Dietary SodiumIBA 08/2012 - 12/2002
2	Natriuretic PeptidesIBA 01/2022 - 01/2010
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2018
2	Bicarbonates (Hydrogen Carbonate)IBA 01/2020 - 09/2015
2	Phosphates (Orthophosphate)IBA 01/2019 - 09/2013
2	AngiotensinsIBA 01/2018 - 12/2004

Therapy/Procedure

54	Therapeutics 01/2021 - 03/2002
9	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2018 - 12/2004
6	Kidney Transplantation 11/2019 - 09/2005
4	Transplantation 01/2019 - 04/2003
4	Nephrectomy 10/2008 - 04/2006
3	Surgical Amputation (Amputations) 11/2019 - 01/2017
3	Glycemic Control 09/2015 - 03/2011
2	Precision Medicine 01/2021 - 10/2018
2	Secondary Prevention 01/2019 - 01/2018